INFLUENCE OF THE CYTOPROTECTIVE AGENT AMIFOSTINE ON TOXICITY AND PHARMACOKINETICS (PK) OF DOCETAXEL (D) IN METASTATIC BREAST-CANCER (MBC) -A FEASIBILITY STUDY OF THE EORTC-INVESTIGATIONAL DRUG BRANCH FOR BREAST-CANCER (IDBBC)
A. Awada et al., INFLUENCE OF THE CYTOPROTECTIVE AGENT AMIFOSTINE ON TOXICITY AND PHARMACOKINETICS (PK) OF DOCETAXEL (D) IN METASTATIC BREAST-CANCER (MBC) -A FEASIBILITY STUDY OF THE EORTC-INVESTIGATIONAL DRUG BRANCH FOR BREAST-CANCER (IDBBC), Annals of oncology, 9, 1998, pp. 208-208